These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31455718)

  • 1. Individualised targets for insulin initiation in type 2 diabetes mellitus-the influence of physician and practice: a cross-sectional study in eight European countries.
    Boels AM; Koning E; Vos RC; Khunti K; Rutten GE
    BMJ Open; 2019 Aug; 9(8):e032040. PubMed ID: 31455718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.
    Mata-Cases M; Benito-Badorrey B; Roura-Olmeda P; Franch-Nadal J; Pepió-Vilaubí JM; Saez M; Coll-de-Tuero G;
    Curr Med Res Opin; 2013 Nov; 29(11):1495-502. PubMed ID: 23944631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries.
    Boels AM; Vos RC; Hermans TGT; Zuithoff NPA; Müller N; Khunti K; Rutten GEHM;
    BMJ Open; 2017 Jul; 7(7):e016180. PubMed ID: 28701411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results from the UK cohort of SOLVE: providing insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice.
    Khunti K; Vora J; Davies M
    Prim Care Diabetes; 2014 Apr; 8(1):57-63. PubMed ID: 24378771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of diabetes care in Slovenia, Croatia, Serbia, Bulgaria and Romania : An observational, non-interventional, cross-sectional study.
    Cokolic M; Lalic NM; Micic D; Mirosevic G; Klobucar Majanovic S; Lefterov IN; Graur M
    Wien Klin Wochenschr; 2017 Mar; 129(5-6):192-200. PubMed ID: 27933508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study.
    Campbell MD; Babic D; Bolcina U; Smirčić-Duvnjak L; Tankova T; Mitrakou A; Kempler P; Janez A
    Acta Diabetol; 2019 Sep; 56(9):1045-1049. PubMed ID: 30993528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
    Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
    Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England.
    Heald AH; Fryer AA; Anderson SG; Livingston M; Lunt M; Davies M; Moreno GYC; Gadsby R; Young RJ; Stedman M
    Diabetes Obes Metab; 2018 Jul; 20(7):1659-1669. PubMed ID: 29516618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment patterns among older patients with type 2 diabetes in the United States: a retrospective cohort study.
    Fu H; Curtis BH; Schuster DP; Festa A; Kendall DM
    Diabetes Technol Ther; 2014 Dec; 16(12):833-9. PubMed ID: 25068375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study.
    Stone MA; Charpentier G; Doggen K; Kuss O; Lindblad U; Kellner C; Nolan J; Pazderska A; Rutten G; Trento M; Khunti K;
    Diabetes Care; 2013 Sep; 36(9):2628-38. PubMed ID: 23628621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of English general practice level data linking medication levels, service activity and demography to levels of glycaemic control being achieved in type 2 diabetes to improve clinical practice and patient outcomes.
    Heald A; Davies M; Stedman M; Livingston M; Lunt M; Fryer A; Gadsby R
    BMJ Open; 2019 Sep; 9(9):e028278. PubMed ID: 31494602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treat-to-target HbA
    Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
    Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment.
    Mata-Cases M; Franch-Nadal J; Real J; Gratacòs M; López-Simarro F; Khunti K; Mauricio D
    Diabetes Obes Metab; 2018 Jan; 20(1):103-112. PubMed ID: 28656746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin.
    Khunti K; Nikolajsen A; Thorsted BL; Andersen M; Davies MJ; Paul SK
    Diabetes Obes Metab; 2016 Apr; 18(4):401-9. PubMed ID: 26743666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician perspectives on de-intensifying diabetes medications.
    Genere N; Sargis RM; Masi CM; Nathan AG; Quinn MT; Huang ES; Laiteerapong N
    Medicine (Baltimore); 2016 Nov; 95(46):e5388. PubMed ID: 27861373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries.
    Hermans MP; Brotons C; Elisaf M; Michel G; Muls E; Nobels F;
    Eur J Prev Cardiol; 2013 Dec; 20(6):1095-105. PubMed ID: 22605788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Greek registry of current type 2 diabetes management, aiming to determine core clinical approaches, patterns and strategies.
    Liatis S; Iraklianou S; Kazakos K; Mastorakos G; Milios K; Mouslech Z; Noutsou M; Pagkalos E; Sampanis C;
    BMC Endocr Disord; 2019 Apr; 19(1):39. PubMed ID: 31023374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes after insulin initiation in patients with type 2 diabetes: 6-month data from the INSTIGATE observational study in five European countries.
    Liebl A; Jones S; Benroubi M; Castell C; Goday A; Aline Charles M; Smith HT; Nicolay C; Simpson A
    Curr Med Res Opin; 2011 May; 27(5):887-95. PubMed ID: 21341946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales.
    Datta-Nemdharry P; Thomson A; Beynon J; Donegan K
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):127-135. PubMed ID: 27642000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of insulin as a first-line therapy and associated factors in people with type 2 diabetes in German primary care practices.
    van den Boom L; Kaiser M; Kostev K
    Diabet Med; 2020 Aug; 37(8):1333-1339. PubMed ID: 32506471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.